1.
Prima Sanjiwani Saraswati Sudarsa, Mario Korwa, Nyoman Suryawati. Therapeutic Outcomes of Secukinumab 300 mg in Severe Psoriasis Vulgaris with Metabolic Comorbidities: A Retrospective Cohort Study in Bali. Bioscmed [Internet]. 2026Jan.21 [cited 2026Feb.11];10(4):1048-96. Available from: https://bioscmed.com/index.php/bsm/article/view/1552